View in EDS

A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.

Saved in:
Bibliographic Details
Title: A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Authors: Mayer, K. A.1, Schrezenmeier, E.2, Diebold, M.1,3, Halloran, P. F.4, Schatzl, M.1, Schranz, S.5, Haindl, S.1, Kasbohm, S.2, Kainz, A.1, Eskandary, F.1, Doberer, K.1, Patel, U. D.6, Dudani, J. S.6, Regele, H.7, Kozakowski, N.7, Kläger, J.7, Boxhammer, R.8, Amann, K.9, Puchhammer-Stöckl, E.10, Vietzen, H.10
Source: New England Journal of Medicine. 7/11/2024, Vol. 391 Issue 2, p122-132. 11p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 178489199
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Mayer%2C+K%2E+A%2E%22">Mayer, K. A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Schrezenmeier%2C+E%2E%22">Schrezenmeier, E.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Diebold%2C+M%2E%22">Diebold, M.</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Halloran%2C+P%2E+F%2E%22">Halloran, P. F.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Schatzl%2C+M%2E%22">Schatzl, M.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Schranz%2C+S%2E%22">Schranz, S.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Haindl%2C+S%2E%22">Haindl, S.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Kasbohm%2C+S%2E%22">Kasbohm, S.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kainz%2C+A%2E%22">Kainz, A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Eskandary%2C+F%2E%22">Eskandary, F.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Doberer%2C+K%2E%22">Doberer, K.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Patel%2C+U%2E+D%2E%22">Patel, U. D.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Dudani%2C+J%2E+S%2E%22">Dudani, J. S.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Regele%2C+H%2E%22">Regele, H.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Kozakowski%2C+N%2E%22">Kozakowski, N.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Kläger%2C+J%2E%22">Kläger, J.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Boxhammer%2C+R%2E%22">Boxhammer, R.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Amann%2C+K%2E%22">Amann, K.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Puchhammer-Stöckl%2C+E%2E%22">Puchhammer-Stöckl, E.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Vietzen%2C+H%2E%22">Vietzen, H.</searchLink><relatesTo>10</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22New+England+Journal+of+Medicine%22">New England Journal of Medicine</searchLink>. 7/11/2024, Vol. 391 Issue 2, p122-132. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=178489199
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1056/NEJMoa2400763
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 122
    Titles:
      – TitleFull: A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mayer, K. A.
      – PersonEntity:
          Name:
            NameFull: Schrezenmeier, E.
      – PersonEntity:
          Name:
            NameFull: Diebold, M.
      – PersonEntity:
          Name:
            NameFull: Halloran, P. F.
      – PersonEntity:
          Name:
            NameFull: Schatzl, M.
      – PersonEntity:
          Name:
            NameFull: Schranz, S.
      – PersonEntity:
          Name:
            NameFull: Haindl, S.
      – PersonEntity:
          Name:
            NameFull: Kasbohm, S.
      – PersonEntity:
          Name:
            NameFull: Kainz, A.
      – PersonEntity:
          Name:
            NameFull: Eskandary, F.
      – PersonEntity:
          Name:
            NameFull: Doberer, K.
      – PersonEntity:
          Name:
            NameFull: Patel, U. D.
      – PersonEntity:
          Name:
            NameFull: Dudani, J. S.
      – PersonEntity:
          Name:
            NameFull: Regele, H.
      – PersonEntity:
          Name:
            NameFull: Kozakowski, N.
      – PersonEntity:
          Name:
            NameFull: Kläger, J.
      – PersonEntity:
          Name:
            NameFull: Boxhammer, R.
      – PersonEntity:
          Name:
            NameFull: Amann, K.
      – PersonEntity:
          Name:
            NameFull: Puchhammer-Stöckl, E.
      – PersonEntity:
          Name:
            NameFull: Vietzen, H.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 07
              Text: 7/11/2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 00284793
          Numbering:
            – Type: volume
              Value: 391
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: New England Journal of Medicine
              Type: main
ResultId 1